Skip to main content
BIIB
NASDAQ Life Sciences

Biogen to Acquire RayThera for Up to $1 Billion, Bolstering Immunology Pipeline

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$199.58
Mkt Cap
$29.331B
52W Low
$121.05
52W High
$205.97
52W Position info
65% above low
Off High info
3.1% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

BIIB sits 65% above its 52-week low of $121.05.

Summary

Biogen announced an agreement to acquire private biotechnology company RayThera for up to $1 billion. This strategic move aims to expand Biogen's pipeline in immunology. This follows the company's recent completion of the $5.3 billion Apellis Pharmaceuticals acquisition in May, indicating continued focus on M&A for pipeline growth. The $1 billion investment is a material commitment to its immunology franchise.

At the time of this announcement, BIIB was trading at $199.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $29.3B. The 52-week trading range was $121.05 to $205.97. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

BIIB - Latest Insights

BIIB
Nov 18, 2026, 11:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $249.28
Real-time Price: $249.28 info
Change: $0 (0%) info
Market Cap: $36.894B info
BIIB
Nov 17, 2026, 4:45 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $253.00
Real-time Price: $249.28 info
Change: -$3.72 (-1%) info
Market Cap: $36.894B info
BIIB
Nov 09, 2026, 1:02 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $248.35
Real-time Price: $249.28 info
Change: +$0.930 (+0.37%) info
Market Cap: $36.894B info
BIIB
Oct 28, 2026, 6:23 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $252.73
Real-time Price: $249.28 info
Change: -$3.45 (-1%) info
Market Cap: $36.894B info
BIIB
Oct 28, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $252.73
Real-time Price: $249.28 info
Change: -$3.45 (-1%) info
Market Cap: $36.894B info